Aethlon Medical's Hemopurifier® device is being used for treating Long COVID and CAC.
3 reports, 3 independent
Updated Jun 26
Gone quiet
Reached 2 outlets in its first 24 hours
- Reports
- 3
- Developments
- 2
- Repetition
- 67%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Aethlon Medical's Hemopurifier® device is being used for treating Long COVID and CAC.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Hospital systems like Cleveland Clinic are utilizing the technology associated with HEMOBLAST Bellows, which involves Nvidia.Sub-event
Hemopurifier® device application for Long COVID and CAC.1 source
Keep exploring
The entities involved
-
Aethlon Medical
Nothing else this week.
Coverage
Newest first; wire copies grouped- investorideas.com
- PR NewswireAethlon Medical Announces Issuance of Hemopurifier® Patents for the Treatment of Long COVID and COVID-19-associated Coagulopathy (CAC) SAN DIEGO, Sept. 3, 2025 /PRNewswire/ -- Aethlon Medical, Inc. (
- Zacks Small Cap ResearchAEMD: No SAEs in Cohort 1 Post-Hemopurifier Treatment; Progressing Trial to Cohort 2 By M. Marin NASDAQ:AEMD READ THE FULL AEMD RESEARCH REPORT Data Safety Monitoring Board Recommends Progressing Tri